T1	PrimaryOutcome 50 119	mechanical ventilation, hospitalization >14 days or in-hospital death
T2	SecondaryOutcome 151 181	days of mechanical ventilation
T3	SecondaryOutcome 183 221	days of high-flow nasal cannula (HFNC)
T4	SecondaryOutcome 223 249	days of oxygen requirement
T5	SecondaryOutcome 251 306	time to respiratory failure development (PaO2/FiO2<200)
T6	SecondaryOutcome 312 366	severity of multiple organ dysfunction (by SOFA score)
T7	TimeFrame 367 381	at day 3 and 7
R1	MeasuredAt Arg1:T6 Arg2:T7	
T8	SecondaryOutcome 383 420	days in ICU or intermediate care unit
T9	SecondaryOutcome 422 445	hospital length of stay
T10	SecondaryOutcome 451 460	mortality
T11	TimeFrame 461 471	at 30 days
R2	MeasuredAt Arg1:T10 Arg2:T11	
T12	SecondaryOutcome 755 810	comparison of infiltrates progression on chest CT scans
T13	TimeFrame 811 834	on enrollment and day 5
R3	MeasuredAt Arg1:T12 Arg2:T13	
T14	OtherOutcome 1048 1118	pre-planned analyses of baseline neutralizing antibodies (NAbs) titers
T15	OtherOutcome 1124 1150	anti-SARS-CoV-2 IgG titers
T16	TimeFrame 1308 1326	on days 0, 3 and 7
R4	MeasuredAt Arg1:T15 Arg2:T16	
R5	MeasuredAt Arg1:T14 Arg2:T16	
